首页> 外国专利> Diphenylbutadic acid, as an alternative derivative of NEP inhibitor, was changed into EFIC Acia in vivo

Diphenylbutadic acid, as an alternative derivative of NEP inhibitor, was changed into EFIC Acia in vivo

机译:在体内将二苯丁酸作为NEP抑制剂的替代衍生物更改为EFIC Acia

摘要

The present Invention provides a compound of formula I, or a pharmaceutically acceptable Salt thereof, wherein X is as defined herein. The Invention also relates to a method for Manufacturing the compounds of the Invention and their Therapeutic uses.The present Invention also provides the pharmaceutical Composition of the compounds of the Invention and a combination of pharmacologically Active agents and a compound of the invention.
机译:本发明提供式I化合物或其药学上可接受的盐,其中X如本文所定义。本发明还涉及用于制造本发明化合物及其治疗用途的方法。本发明还提供了本发明化合物的药物组合物,以及药理活性剂和本发明化合物的组合。

著录项

  • 公开/公告号UY35323A

    专利类型

  • 公开/公告日2014-09-30

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号UY20140035323

  • 发明设计人 DAVID WENINGER BARNES;DEAN FRANKLIN RIGEL;

    申请日2014-02-13

  • 分类号A61P9;A61K31/4245;C07C235/82;C07D271/07;

  • 国家 UY

  • 入库时间 2022-08-21 15:56:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号